Patent: 10,213,425
✉ Email this page to a colleague
Summary for Patent: 10,213,425
Title: | Role of N-2-hydroxy-ethyl-piperazine-N\'-2-ethane sulfonic acid (HEPES) in pain control and reversal of demyelinization injury |
Abstract: | Compositions and therapeutic uses of HEPES and derivatives in the treatment of pain associated with cancers and side-effects including post-chemotherapy cognitive impairment are disclosed herein. HEPES is also used to treat neurodegenerative and neurological diseases, demyelinization injuries, and side-effects and withdrawal symptoms associated with benzodiazepines, anti-depressants, and other neurological agents. |
Inventor(s): | Danhof; Ivan E. (Grand Prairie, TX) |
Assignee: | BESPOKE BIOSCIENCE, LLC (Dallas, TX) |
Application Number: | 15/725,007 |
Patent Claims: | see list of patent claims |
Details for Patent 10,213,425
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Merck Sharp & Dohme Corp. | ZOSTAVAX | zoster vaccine live | For Injection | 125123 | 05/25/2006 | ⤷ Try a Trial | 2029-09-17 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |